J Schedel

523 total citations
22 papers, 366 citations indexed

About

J Schedel is a scholar working on Rheumatology, Oncology and Epidemiology. According to data from OpenAlex, J Schedel has authored 22 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Rheumatology, 7 papers in Oncology and 5 papers in Epidemiology. Recurrent topics in J Schedel's work include Systemic Lupus Erythematosus Research (4 papers), Inflammatory Myopathies and Dermatomyositis (4 papers) and Rheumatoid Arthritis Research and Therapies (4 papers). J Schedel is often cited by papers focused on Systemic Lupus Erythematosus Research (4 papers), Inflammatory Myopathies and Dermatomyositis (4 papers) and Rheumatoid Arthritis Research and Therapies (4 papers). J Schedel collaborates with scholars based in Germany, United States and Switzerland. J Schedel's co-authors include Nikolay Tzaribachev, I. Koetter, Jasmin Kuemmerle‐Deschner, Ulf Müller‐Ladner, Jürgen Schölmerich, Claudia Weidler, Oliver Distler, Peter Härle, Rainer H. Straub and Martin Schmidt and has published in prestigious journals such as Annals of the New York Academy of Sciences, Annals of the Rheumatic Diseases and Gene Therapy.

In The Last Decade

J Schedel

21 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Schedel Germany 12 136 94 81 63 44 22 366
María López‐Lasanta Spain 11 160 1.2× 87 0.9× 107 1.3× 56 0.9× 21 0.5× 19 439
C Charpin France 12 139 1.0× 48 0.5× 76 0.9× 56 0.9× 79 1.8× 25 409
Toshiaki Tsukada Japan 11 122 0.9× 115 1.2× 64 0.8× 51 0.8× 67 1.5× 20 320
Haruka Tsuchiya Japan 14 188 1.4× 111 1.2× 196 2.4× 80 1.3× 80 1.8× 31 512
Lisa Kaly Israel 10 121 0.9× 116 1.2× 82 1.0× 30 0.5× 40 0.9× 46 402
H Gatica Chile 13 226 1.7× 71 0.8× 89 1.1× 118 1.9× 44 1.0× 36 522
Isamu Kingetsu Japan 11 102 0.8× 104 1.1× 93 1.1× 32 0.5× 132 3.0× 24 355
Sara S. McCoy United States 13 194 1.4× 69 0.7× 81 1.0× 50 0.8× 37 0.8× 38 519
R Rondinone Italy 10 123 0.9× 48 0.5× 57 0.7× 65 1.0× 111 2.5× 19 366
Mihoko Shibuya Japan 10 106 0.8× 82 0.9× 233 2.9× 110 1.7× 20 0.5× 15 494

Countries citing papers authored by J Schedel

Since Specialization
Citations

This map shows the geographic impact of J Schedel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Schedel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Schedel more than expected).

Fields of papers citing papers by J Schedel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Schedel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Schedel. The network helps show where J Schedel may publish in the future.

Co-authorship network of co-authors of J Schedel

This figure shows the co-authorship network connecting the top 25 collaborators of J Schedel. A scholar is included among the top collaborators of J Schedel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Schedel. J Schedel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Finkenzeller, Thomas, et al.. (2015). Transcatheter arterial embolisation in upper gastrointestinal bleeding in a sample of 29 patients in a gastrointestinal referral center in Germany. Zeitschrift für Gastroenterologie. 53(9). 1071–1079. 4 indexed citations
3.
Schedel, J, et al.. (2011). Autoinflammatorische Syndrome/Fiebersyndrome. Der Hautarzt. 62(5). 389–402. 6 indexed citations
4.
Schedel, J, et al.. (2010). Cerebral lesions in patients with connective tissue diseases and systemic vasculitides: are there specific patterns?. Annals of the New York Academy of Sciences. 1193(1). 167–175. 5 indexed citations
5.
Tzaribachev, Nikolay, et al.. (2009). Whole-body MRI: a helpful diagnostic tool for juvenile dermatomyositis case report and review of the literature. Rheumatology International. 29(12). 1511–1514. 22 indexed citations
6.
Tzaribachev, Nikolay, I. Koetter, Jasmin Kuemmerle‐Deschner, & J Schedel. (2009). Rituximab for the treatment of refractory pediatric autoimmune diseases: a case series. Cases Journal. 2(1). 6609–6609. 40 indexed citations
7.
Kötter, Ina, J Schedel, & Jasmin Kümmerle‐Deschner. (2009). Periodische Fiebersyndrome/autoinflammatorische Syndrome. Zeitschrift für Rheumatologie. 68(2). 137–149. 6 indexed citations
8.
Schubert, Thomas, et al.. (2009). Role of the Netrin System of Repellent Factors on Synovial Fibroblasts in Rheumatoid Arthritis and Osteoarthritis. International Journal of Immunopathology and Pharmacology. 22(3). 715–722. 17 indexed citations
9.
Tzaribachev, Nikolay, I. Koetter, Jasmin Kuemmerle‐Deschner, & J Schedel. (2009). Rituximab for the treatment of refractory pediatric autoimmune diseases: a case series.. PubMed. 2. 6609–6609. 37 indexed citations
10.
Schedel, J, et al.. (2004). Autoimmuncholangitis mit vaskulitischen Ulzera, rheumatoider Arthritis und IgA-Glomerulonephritis. DMW - Deutsche Medizinische Wochenschrift. 129(45). 2409–2412.
11.
Schedel, J, Christina Wenglén, Oliver Distler, et al.. (2004). Differential Adherence of Osteoarthritis and Rheumatoid Arthritis Synovial Fibroblasts to Cartilage and Bone Matrix Proteins and its Implication for Osteoarthritis Pathogenesis. Scandinavian Journal of Immunology. 60(5). 514–523. 24 indexed citations
12.
Schedel, J, et al.. (2004). Discrepancy between mRNA and protein expression of tumour suppressor maspin in synovial tissue may contribute to synovial hyperplasia in rheumatoid arthritis. Annals of the Rheumatic Diseases. 63(10). 1205–1211. 36 indexed citations
13.
Schedel, J, Christian A. Seemayer, Thomas Pap, et al.. (2004). Targeting cathepsin L (CL) by specific ribozymes decreases CL protein synthesis and cartilage destruction in rheumatoid arthritis. Gene Therapy. 11(13). 1040–1047. 42 indexed citations
14.
Studýnková, Jana Tomasová, Stefan Kuchen, J Schedel, et al.. (2004). The expression of cyclooxygenase-1, cyclooxygenase-2 and 5-lipoxygenase in inflammatory muscle tissue of patients with polymyositis and dermatomyositis.. PubMed. 22(4). 395–402. 15 indexed citations
15.
Weidler, Claudia, Peter Härle, J Schedel, et al.. (2004). Patients with rheumatoid arthritis and systemic lupus erythematosus have increased renal excretion of mitogenic estrogens in relation to endogenous antiestrogens.. PubMed. 31(3). 489–94. 49 indexed citations
16.
Schedel, J, et al.. (2000). Gene therapy in osteoarthritis. Joint Bone Spine. 67(6). 570–571. 9 indexed citations
17.
Guingamp, Corinne, et al.. (2000). Thérapie génique de l’arthrose. Revue du Rhumatisme. 67(9). 686–687. 1 indexed citations
18.
Krenn, Veit, J Schedel, Frank Gohlke, et al.. (1997). Endothelial cells are the major source of sICAM-1 in rheumatoid synovial tissue. Rheumatology International. 17(1). 17–27. 15 indexed citations
19.
Steinkamp, H., et al.. (1994). Spiral-CT von zervikalen Lymphknotenvergrößerungen. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 160(6). 500–505. 5 indexed citations
20.
Kalden, Joachim R., et al.. (1976). ESTIMATION OF T‐ AND K‐CELL ACTIVITY IN THE PERIPHERAL BLOOD OF SARCOIDOSIS PATIENTS. Annals of the New York Academy of Sciences. 278(1). 52–67. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026